Profile	GDS3514 / 219355_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	39.896	16
GSM325241	Patient no. 1: treated	32.8112	10
GSM325242	Patient no. 9: control	68.4589	20
GSM325243	Patient no. 9: treated	24.5867	9
GSM325244	Patient no. 18: control	171.988	29
GSM325245	Patient no. 18: treated	19.5078	5
GSM325246	Patient no. 12: control	8.0813	3
GSM325247	Patient no. 12: treated	10.8462	5
GSM325248	Patient no. 3: control	205.954	43
GSM325249	Patient no. 3: treated	247.176	47
GSM325250	Patient no. 7: control	71.719	23
GSM325251	Patient no. 7: treated	4.82265	1
GSM325252	Patient no. 15: control	12.2109	4
GSM325253	Patient no. 15: treated	66.7004	19
GSM325254	Patient no. 4: control	9.75028	3
GSM325255	Patient no. 4: treated	7.9674	2
GSM325256	Patient no. 19: control	1281.05	79
GSM325257	Patient no. 19: treated	696.787	68
GSM325258	Patient no. 14: control	24.6029	8
GSM325259	Patient no. 14: treated	67.8642	17
GSM325260	Patient no. 13: control	7.75493	1
GSM325261	Patient no. 13: treated	8.54341	1
GSM325262	Patient no. 17: control	14.4301	6
GSM325263	Patient no. 17: treated	9.00393	1
GSM325264	Patient no. 10: control	74.8655	22
GSM325265	Patient no. 10: treated	13.9323	4
GSM325266	Patient no. 5: control	1028.66	73
GSM325267	Patient no. 5: treated	1334.2	79
GSM325268	Patient no. 11: control	210.47	36
GSM325269	Patient no. 11: treated	19.8885	8
GSM325270	Patient no. 6: control	35.2891	6
GSM325271	Patient no. 6: treated	11.2651	4
GSM325272	Patient no. 8: control	14.3869	4
GSM325273	Patient no. 8: treated	20.958	7
GSM325274	Patient no. 16: control	38.7992	15
GSM325275	Patient no. 16: treated	9.08469	2
GSM325276	Patient no. 2: control	2479.42	87
GSM325277	Patient no. 2: treated	599.41	66